Freeze Drying vs Spray Drying in Pharmaceuticals

9/30/202613 min read

Introduction
The Fundamental Difference Between the Two Processes
How Freeze Drying Removes Water
How Spray Drying Removes Water
Freeze Drying vs Spray Drying: Key Differences
Product Stability and Thermal Stress
Product Structure and Particle Characteristics
Formulation Considerations
Pharmaceutical Applications
Process Development and Scale-Up
Practical & Engineering Considerations
Technical Considerations
How Scientists Choose Between the Two Technologies
Conclusion
Recommended Textbooks
Selected Scientific Literature

1. Introduction

Removing water can fundamentally change the stability, handling, and delivery characteristics of a pharmaceutical product. Two established technologies used for this purpose are freeze drying (lyophilization) and spray drying.

Although both convert a liquid formulation into a dry solid, they do so through fundamentally different physical mechanisms.

Freeze drying first freezes the formulation and subsequently removes ice by sublimation under reduced pressure, followed by removal of remaining unfrozen water during secondary drying. Spray drying, in contrast, atomizes a liquid feed into small droplets and rapidly removes solvent by evaporation as those droplets pass through a drying gas.

This difference has consequences far beyond process temperature. It affects the thermal and interfacial stresses experienced by the formulation, the structure of the resulting solid, particle size and morphology, achievable throughput, equipment requirements, residual moisture, and ultimately the suitability of the product for a particular dosage form or route of administration.

For pharmaceutical scientists, the question is therefore not simply whether freeze drying or spray drying is "better." The relevant question is:

Which drying mechanism produces the required product attributes while maintaining acceptable stability, process robustness, and manufacturing economics?

Both technologies can be appropriate, but they solve different pharmaceutical processing problems. Spray drying, in particular, has become an important particle-engineering platform for pharmaceutical powders, while freeze drying remains an important approach for dehydrating sensitive pharmaceutical and biological formulations.

2. The Fundamental Difference Between the Two Processes

The most important distinction is the state of water during removal.

Freeze drying

In freeze drying, most of the formulation water is converted to ice during freezing. During primary drying, the chamber pressure is reduced and heat is supplied to the frozen product. Ice then undergoes sublimation:

Ice → Water vapor

The vapor travels through the porous dried layer and is captured by the condenser.

The product therefore passes through a frozen state before substantial water removal occurs.

For a deeper understanding of this mechanism, see What Is Sublimation? The Foundation of Freeze Drying, which explains why sublimation is central to pharmaceutical lyophilization.

Spray drying

In spray drying, the liquid feed is atomized into droplets, creating a very large surface area for mass transfer. A drying gas—commonly heated air or nitrogen—contacts the droplets and causes solvent to evaporate:

Liquid water → Water vapor

As evaporation proceeds, the droplets become progressively concentrated and eventually form dry particles.

The critical physical difference can therefore be summarized in words.

Freeze drying removes water primarily through sublimation from a frozen matrix, whereas spray drying removes solvent through evaporation from atomized liquid droplets.

This distinction is important because drying technology is also a product-engineering decision. Freeze drying generally produces a macroscopic porous cake, whereas spray drying can deliberately engineer individual particles with specific size, morphology, density, and porosity.

3. How Freeze Drying Removes Water

Freeze drying is normally divided into three stages.

Freezing

The formulation is cooled until ice forms. As ice crystallizes, water is removed from the concentrated unfrozen phase, causing the remaining solutes to become increasingly concentrated.

Freezing therefore does more than simply lower the temperature. It determines the physical structure of the frozen matrix and can influence ice crystal size, pore structure, solute distribution, and subsequent drying behavior.

The freezing history can consequently influence the final dried cake and the resistance encountered during primary drying.

This is why concepts such as Ice Nucleation in Lyophilization, Freezing Rate in Freeze Drying, Ice Crystal Formation and Growth, and Freeze Concentration During Lyophilization are important when interpreting freeze-drying behavior.

Primary drying

During primary drying, the chamber pressure is reduced below the vapor pressure conditions required for ice sublimation.

Heat is transferred from the shelf through the vial and product toward the sublimation interface. The supplied energy provides the latent heat required for sublimation.

Water vapor then travels through the partially dried product toward the chamber and condenser.

The rate of primary drying is therefore governed by the interaction between:

heat transfer into the product,
the vapor pressure driving force,
resistance to vapor flow through the dried layer,
product temperature,
chamber pressure,
and the evolving structure of the dried cake.

These relationships are explored in greater detail in Primary Drying vs Secondary Drying Explained, Heat and Mass Transfer in Lyophilization: An Introduction, and Product Resistance (Rp): Fundamentals.

Secondary drying

After most visible ice has been removed, water associated with the formulation matrix remains.

Secondary drying increases product temperature under reduced pressure to remove a portion of this bound or adsorbed water.

The final residual moisture becomes an important product attribute because it can influence physical stability, chemical degradation, protein mobility, and storage stability.

The complete process is therefore highly dependent on the thermal history and formulation behavior of the product.

4. How Spray Drying Removes Water

Spray drying approaches the same problem from a very different direction.

Step 1: Feed preparation

The API and excipients are dissolved, dispersed, or suspended in a suitable liquid feed.

Feed properties such as:

solids concentration,
viscosity,
surface tension,
solvent composition,
and feed stability

can strongly influence atomization and particle formation.

Step 2: Atomization

The feed is converted into droplets through a nozzle or atomizer.

This step is fundamental because reducing the liquid into small droplets dramatically increases the surface-area-to-volume ratio.

A large interfacial area allows rapid heat and mass transfer between the droplets and drying gas.

Step 3: Droplet drying

The droplets enter the drying chamber and solvent evaporates.

Importantly, the drying-gas inlet temperature should not be interpreted as the temperature experienced by the product throughout the entire process. Evaporative cooling can keep particle temperatures substantially below the inlet-gas temperature, depending on the process conditions and stage of drying.

As solvent is removed, dissolved material becomes concentrated and eventually forms a solid particle.

Step 4: Powder collection

The dried particles are separated from the gas stream using equipment such as cyclones, filters, or other powder-collection systems.

The result is generally a free-flowing powder rather than a vial cake.

Spray drying is therefore not merely a dehydration technology. It is also a particle-engineering technology.

Process variables can influence:

particle size,
morphology,
density,
porosity,
residual solvent or moisture,
crystallinity,
amorphous content,
and powder flow.

These attributes can be particularly important for inhalation and other applications requiring defined powder properties.

5. Freeze Drying vs Spray Drying: Key Differences

The two processes should be compared across several dimensions rather than by temperature alone.

Process mechanism

Freeze drying relies primarily on sublimation of ice under vacuum.

Spray drying relies on evaporative drying of atomized droplets.

This fundamental distinction determines the subsequent process behavior.

For freeze drying, the transition from liquid formulation to frozen matrix is particularly important because the freezing step establishes the structure through which vapor must later travel. For spray drying, the formation and drying of individual droplets controls the characteristics of the resulting powder.

Temperature

Freeze drying operates with the product initially frozen and generally maintains relatively low product temperatures during primary drying.

Spray drying uses a heated drying gas. However, the relevant parameter for product stability is the actual particle temperature and thermal history, not simply the inlet-gas temperature.

Consequently, spray drying should not automatically be considered unsuitable for thermolabile molecules.

With appropriate formulation and process design, spray drying can be used for certain sensitive pharmaceutical and biological materials.

For freeze drying, the temperature constraints are closely related to product temperature, collapse temperature, and the physical state of the formulation. These concepts are discussed further in Collapse Temperature in Lyophilization, Glass Transition Temperature (Tg′ vs Tg), and Product Temperature in Lyophilization.

Processing time

Freeze drying is generally a long process because freezing, primary drying, and secondary drying can collectively require many hours or longer depending on the product and cycle.

Spray drying is substantially faster because droplets have a very high surface area and drying occurs continuously as they move through the drying chamber.

This difference has major implications for manufacturing throughput.

Product structure

Freeze drying generally produces a porous cake within the container.

Spray drying produces individual particles whose size and morphology can be engineered through formulation and atomization conditions.

For some pharmaceutical applications, the ability to control particle properties is an advantage of spray drying.

Throughput

Spray drying is particularly attractive when high throughput and continuous powder production are important.

Freeze drying is typically more batch-oriented and involves longer residence times.

Equipment

A pharmaceutical freeze dryer requires systems for:

refrigeration,
shelves,
vacuum generation,
condenser operation,
chamber pressure control,
and stoppering.

A spray dryer requires systems for:

feed delivery,
atomization,
drying-gas handling,
temperature control,
powder separation,
and collection.

The engineering challenges are therefore fundamentally different.

The equipment-side fundamentals of freeze drying are explored in Pharmaceutical Freeze Dryer Components Explained, while Shelf Systems in Lyophilization and Shelf Temperature Control Systems provide more detail on the thermal side of the process.

6. Product Stability and Thermal Stress

One of the most important reasons freeze drying became established for pharmaceutical products is its ability to produce a dry solid without requiring conventional high-temperature evaporative drying of the bulk product.

This can be valuable for highly temperature-sensitive biological molecules.

However, low temperature does not mean low stress.

Freeze drying introduces several stresses that can affect proteins and other sensitive molecules, including:

freezing stress,
ice–liquid interfaces,
concentration of solutes in the unfrozen phase,
pH shifts,
changes in ionic strength,
dehydration,
and interfacial effects.

The freezing step itself can therefore be a major determinant of product stability.

Spray drying introduces a different combination of stresses.

These may include:

air–liquid interfacial exposure,
atomization stress,
rapid concentration,
dehydration,
thermal exposure,
and potentially mechanical stress during powder handling.

For proteins, the interaction between formulation composition and drying conditions becomes particularly important.

The appropriate comparison is therefore not:

"Cold process versus hot process."

It is:

"Which combination of physical and chemical stresses can the formulation tolerate while achieving the required final product attributes?"

This distinction is particularly important when evaluating biopharmaceuticals. Drying technology selection for biological products depends on molecular properties, formulation, intended route of administration, stability requirements, and the characteristics required of the final dry product.

7. Product Structure and Particle Characteristics

This is one of the clearest differences between the two technologies.

Freeze-dried product

A conventional lyophilized product typically retains the spatial structure created during freezing.

Ice crystals occupy regions of the frozen matrix. When the ice sublimes, these regions become pores.

The resulting cake can therefore have a highly porous interconnected structure.

This structure can influence:

vapor transport during drying,
reconstitution,
specific surface area,
mechanical strength,
and cake appearance.

The relationship between freezing and final morphology is discussed further in Impact of Freezing on Product Morphology and Ice Crystal Formation and Growth.

Spray-dried product

Spray drying produces particles directly from individual droplets.

The final particle morphology depends on the drying trajectory of each droplet and can range from relatively dense to hollow, porous, wrinkled, or otherwise structured particles.

Particle engineering can therefore be deliberately used to achieve specific pharmaceutical objectives.

This becomes particularly important for pulmonary drug delivery, where aerodynamic diameter, density, particle morphology, dispersibility, and powder flow can affect aerosol performance. Spray drying has consequently become an important platform for pharmaceutical inhalation formulations and other engineered powder systems.

8. Formulation Considerations

The formulation cannot be separated from the drying technology.

A formulation that performs well during freeze drying may not necessarily perform well during spray drying, and vice versa.

Freeze drying

Formulation development commonly considers:

glass transition temperature of the maximally freeze-concentrated phase (Tg′),
collapse temperature,
crystallization behavior,
cryoprotective and lyoprotective effects,
buffer behavior,
protein concentration,
and residual moisture requirements.

The formulation must remain sufficiently stable during freezing and drying while producing an acceptable cake and reconstitution profile.

These considerations connect directly to Cryoprotectants in Lyophilization, Lyoprotectants in Freeze Drying, Role of Sugars (Sucrose & Trehalose), and Formulation Development for Lyophilized Products.

Spray drying

Spray-drying formulations may require careful consideration of:

feed solids concentration,
viscosity,
surface tension,
solvent system,
atomization behavior,
excipient selection,
glass-transition behavior of the dried matrix,
particle morphology,
hygroscopicity,
and powder flow.

For poorly soluble small molecules, spray drying is also widely used to create amorphous systems or other engineered particles that can improve dissolution and apparent solubility.

This is an important conceptual difference:

Freeze drying often prioritizes preservation of a stable pharmaceutical formulation in a vial, whereas spray drying can simultaneously be used to manufacture the required powder architecture.

9. Pharmaceutical Applications

Neither technology is restricted to a single type of pharmaceutical product.

Applications of freeze drying

Freeze drying is widely used for products where long-term stability in a dry state is important, particularly when the formulation is sensitive to conventional drying conditions.

Examples include:

injectable biologics,
vaccines,
therapeutic proteins,
peptides,
certain antibiotics,
diagnostic products,
and other temperature-sensitive pharmaceutical formulations.

The final product is frequently packaged as a sterile lyophilized cake that is reconstituted before administration.

For more detail on why this technology is used, see Why Freeze Drying Is Used in Pharmaceuticals and Pharmaceutical Applications of Lyophilization.

Applications of spray drying

Spray drying is used across a broader range of powder-engineering applications, including:

amorphous solid dispersions,
poorly water-soluble APIs,
pharmaceutical excipient systems,
inhalation powders,
microencapsulation,
controlled-release systems,
and selected biopharmaceutical formulations.

Its ability to produce engineered particles is especially useful when the final dosage form requires a powder with specific aerodynamic or dissolution characteristics.

10. Process Development and Scale-Up

The two technologies also present different scale-up problems.

Freeze-drying scale-up

A freeze-drying process is strongly influenced by heat and mass transfer.

Important variables include:

shelf temperature,
chamber pressure,
vial geometry,
fill volume,
product resistance,
heat-transfer coefficient,
condenser capacity,
and product temperature.

Scale-up therefore requires understanding whether the larger equipment reproduces the critical thermal and mass-transfer conditions experienced by the product.

Simply reproducing shelf temperature and chamber pressure is not always sufficient.

These relationships become increasingly important when moving from basic process understanding into Mathematical Modeling of Freeze Drying, Mechanistic Modeling of Lyophilization, and eventually Design Space Development.

Spray-drying scale-up

Spray-drying scale-up involves maintaining comparable droplet formation and drying behavior.

Important variables include:

atomization conditions,
feed rate,
drying-gas flow,
inlet and outlet temperatures,
solids concentration,
droplet size,
residence time,
and powder collection efficiency.

The objective is to maintain the critical particle attributes rather than simply reproduce laboratory equipment settings.

This is a fundamental engineering principle common to both technologies:

Scale-up should preserve the mechanisms controlling product quality, not merely the numerical values of process parameters.

11. Practical & Engineering Considerations

From a manufacturing perspective, the choice between freeze drying and spray drying often involves competing objectives.

Freeze drying may be attractive when:

the formulation requires a low-temperature drying environment;
long-term stability in the dried state is a major objective;
the product is intended for vial-based reconstitution;
preservation of a specific biological structure is critical;
batch processing is acceptable;
and the formulation can tolerate freezing.

Spray drying may be attractive when:

high throughput is important;
a powder rather than a vial cake is required;
particle engineering is important;
the product is intended for pulmonary delivery;
rapid processing is desirable;
an amorphous solid dispersion is required;
or continuous powder production provides a manufacturing advantage.

These are not absolute rules.

A biologic does not automatically require freeze drying, and a small molecule does not automatically favor spray drying.

The formulation, route of administration, stability target, particle requirements, manufacturing scale, and process economics must all be considered together.

12. Technical Considerations

12.1 Thermal exposure is not the only stability variable

It is tempting to compare the technologies simply by saying that freeze drying is "cold" and spray drying is "hot."

That description is incomplete.

For freeze drying, freezing and dehydration stresses can be highly significant.

For spray drying, the particle may experience a relatively short thermal exposure because evaporation provides cooling during much of the drying trajectory.

Consequently, time–temperature history is more informative than a single nominal process temperature.

12.2 Freeze drying can produce excellent stability—but formulation still controls the outcome

A poorly designed freeze-drying formulation can experience collapse, crystallization, degradation, poor reconstitution, or excessive residual moisture.

The technology itself does not guarantee stability.

The formulation and cycle must be designed around the physical properties of the product.

12.3 Spray drying can be compatible with sensitive molecules

Spray drying has historically been associated with thermally robust materials, but modern pharmaceutical applications include increasingly sensitive molecules.

Protective excipients can be used to stabilize proteins during drying, while process optimization can reduce the severity of thermal and interfacial stresses.

Nevertheless, the feasibility of spray drying must be demonstrated experimentally for the specific molecule and formulation rather than assumed from its nominal thermal stability.

12.4 Particle engineering can change the entire product strategy

One of spray drying's major advantages is that the drying process can be used to create a particle with a desired physical architecture.

This is particularly relevant when the final product depends on:

aerodynamic performance,
rapid dissolution,
enhanced surface area,
controlled release,
improved flow,
or encapsulation.

In these applications, spray drying is not merely replacing water removal in a process. It is helping create the dosage-form architecture itself.

13. How Scientists Choose Between the Two Technologies

The most useful way to approach the decision is to start with the required final product, rather than starting with the available dryer.

A scientist should ask:

1. What dosage form is required?

A reconstitutable sterile vial and an inhalation powder impose very different requirements.

2. How sensitive is the molecule to the stresses of each process?

Consider thermal exposure, freezing, dehydration, interfaces, concentration effects, and mechanical stresses.

3. What physical structure is required?

Is a porous cake desirable, or is a defined particle size and morphology required?

4. What are the stability requirements?

The target residual moisture, solid-state form, molecular integrity, and storage conditions must be considered.

5. What manufacturing scale is required?

A technology that works well during formulation screening may not necessarily be the most practical solution for commercial production.

6. What does the route of administration require?

For inhalation, particle engineering can become a dominant consideration. For injectable products requiring reconstitution, the requirements are different.

7. What formulation can support the process?

The formulation must be compatible with the physical stresses imposed by the selected drying technology.

The final decision should therefore emerge from product requirements + formulation behavior + process capability + manufacturing requirements, rather than from a generic claim that one drying technology is superior.

14. Conclusion

Freeze drying and spray drying both convert pharmaceutical liquids into stable dry products, but they do so through fundamentally different mechanisms.

Freeze drying freezes the formulation and removes ice primarily by sublimation under vacuum. Its strength lies in producing dry, porous pharmaceutical products under conditions that can be suitable for highly sensitive formulations, although freezing and dehydration introduce their own stresses.

Spray drying atomizes the formulation and removes solvent through rapid evaporation. Its major strengths include high throughput and the ability to engineer powder characteristics such as particle size and morphology.

The important scientific distinction is therefore not simply low temperature versus high temperature.

It is:

sublimation of a frozen matrix versus evaporation from engineered droplets.

That difference determines the stresses experienced by the formulation, the structure of the dried product, the process timescale, the equipment requirements, and the opportunities for particle engineering.

For pharmaceutical development, neither technology should be considered universally preferable. The appropriate choice depends on the molecule, formulation, desired product attributes, route of administration, stability requirements, and manufacturing strategy.

Understanding the mechanism behind each process allows scientists to make that decision based on product requirements rather than technology preference.

15. Recommended Textbooks

Rey, L. & May, J. C. — Freeze-Drying/Lyophilization of Pharmaceutical and Biological Products
Pikal, M. J. — foundational work on pharmaceutical freeze drying and heat/mass transfer
Franks, F. — foundational work on physical chemistry and stabilization of biological materials during drying

16. Selected Scientific Literature

Vehring, R. — Pharmaceutical Particle Engineering via Spray Drying. Pharmaceutical Research. This review discusses particle formation, morphology, particle engineering, and pharmaceutical applications of spray drying.
Pardeshi, S. et al. — A meticulous overview on drying-based (spray-, freeze-, and spray-freeze) particle engineering approaches for pharmaceutical technologies. Drying Technology. The review examines spray drying, freeze drying, particle engineering, formulation, and scale-up considerations.
Engineering Advances in Spray Drying for Pharmaceuticals. Annual Review of Chemical and Biomolecular Engineering. The review covers pharmaceutical spray drying, amorphous solid dispersions, biologics, inhalation, particle engineering, and scale-up.
Brytan, W., Amorim, R. & Padrela, L. — Process control and design of drying technologies for biopharmaceuticals – A review. Powder Technology, 2025. The review compares drying technologies with respect to process control, particle engineering, and biopharmaceutical stability.

Educational Disclaimer

The information presented in this article is intended exclusively for educational and informational purposes as part of the Lyophilization Core scientific knowledge base. It is designed to support the understanding of pharmaceutical lyophilization science, engineering principles, formulation development, process development, and manufacturing concepts.

This content should not be interpreted as regulatory guidance, GMP instructions, manufacturing procedures, process validation protocols, engineering specifications, or professional consulting advice. The suitability of any lyophilization process, formulation, equipment, or operating condition must be evaluated based on product-specific scientific data, validated procedures, applicable regulatory requirements, and qualified scientific and engineering judgment.

Pharmaceutical development and commercial manufacturing should always be conducted in accordance with applicable Good Manufacturing Practices (GMP), relevant regulatory guidance, approved quality systems, and site-specific standard operating procedures.